158 related articles for article (PubMed ID: 31931932)
1. Effects of Propranolol in Accelerating Wound Healing and Attenuation of Hypermetabolism in Adult Burn Patients.
Cheema SA; Ahmed UT; Nasir H; Dogar SR; Mustafa Z
J Coll Physicians Surg Pak; 2020 Jan; 30(1):46-50. PubMed ID: 31931932
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of propranolol in wound healing for hospitalized burn patients.
Mohammadi AA; Bakhshaeekia A; Alibeigi P; Hasheminasab MJ; Tolide-ei HR; Tavakkolian AR; Mohammadi MK
J Burn Care Res; 2009; 30(6):1013-7. PubMed ID: 19826272
[TBL] [Abstract][Full Text] [Related]
3. Propranolol attenuates hemorrhage and accelerates wound healing in severely burned adults.
Ali A; Herndon DN; Mamachen A; Hasan S; Andersen CR; Grogans RJ; Brewer JL; Lee JO; Heffernan J; Suman OE; Finnerty CC
Crit Care; 2015 May; 19(1):217. PubMed ID: 25936635
[TBL] [Abstract][Full Text] [Related]
4. Low-dose propranolol improves cutaneous wound healing of burn-injured rats.
Romana-Souza B; Nascimento AP; Monte-Alto-Costa A
Plast Reconstr Surg; 2008 Dec; 122(6):1690-1699. PubMed ID: 19050521
[TBL] [Abstract][Full Text] [Related]
5. Beta-blockade in burns.
Pereira CT; Jeschke MG; Herndon DN
Novartis Found Symp; 2007; 280():238-48; discussion 248-51. PubMed ID: 17380798
[TBL] [Abstract][Full Text] [Related]
6. Systematic review of the effect of propanolol on hypermetabolism in burn injuries.
Núñez-Villaveirán T; Sánchez M; Millán P; García-de-Lorenzo A
Med Intensiva; 2015 Mar; 39(2):101-13. PubMed ID: 25305241
[TBL] [Abstract][Full Text] [Related]
7. Reversal of catabolism by beta-blockade after severe burns.
Herndon DN; Hart DW; Wolf SE; Chinkes DL; Wolfe RR
N Engl J Med; 2001 Oct; 345(17):1223-9. PubMed ID: 11680441
[TBL] [Abstract][Full Text] [Related]
8. Effects of pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns.
Diaz EC; Herndon DN; Porter C; Sidossis LS; Suman OE; Børsheim E
Burns; 2015 Jun; 41(4):649-57. PubMed ID: 25468473
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary effect observation on the application of micro-negative pressure in children with small-area deep partial-thickness burn].
Zheng XP; Chen J; Chen TS; Jiang YN; Shen T; Xiao SC; Hu XY
Zhonghua Shao Shang Za Zhi; 2019 Oct; 35(10):720-725. PubMed ID: 31658542
[No Abstract] [Full Text] [Related]
10. A survey of the use of propranolol in burn centers: Who, what, when, why.
LeCompte MT; Rae L; Kahn SA
Burns; 2017 Feb; 43(1):121-126. PubMed ID: 27575676
[TBL] [Abstract][Full Text] [Related]
11. The Safety and Efficacy of Propranolol in Reducing the Hypermetabolic Response in the Pediatric Burn Population.
Ojeda S; Blumenthal E; Stevens P; Andersen CR; Robles L; Herndon DN; Meyer WJ
J Burn Care Res; 2018 Oct; 39(6):963-969. PubMed ID: 29757441
[TBL] [Abstract][Full Text] [Related]
12. Propranolol does not increase inflammation, sepsis, or infectious episodes in severely burned children.
Jeschke MG; Norbury WB; Finnerty CC; Branski LK; Herndon DN
J Trauma; 2007 Mar; 62(3):676-81. PubMed ID: 17414346
[TBL] [Abstract][Full Text] [Related]
13. The use of propranolol in adult burn patients: Safety and outcome influence.
Lam NN; Khanh PQ; An NH
Burns; 2022 Jun; 48(4):767-773. PubMed ID: 34895792
[TBL] [Abstract][Full Text] [Related]
14. Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children.
Jeschke MG; Finnerty CC; Kulp GA; Przkora R; Mlcak RP; Herndon DN
Pediatr Crit Care Med; 2008 Mar; 9(2):209-16. PubMed ID: 18477935
[TBL] [Abstract][Full Text] [Related]
15. Beta-blocker use is associated with improved outcomes in adult burn patients.
Arbabi S; Ahrns KS; Wahl WL; Hemmila MR; Wang SC; Brandt MM; Taheri PA
J Trauma; 2004 Feb; 56(2):265-9; discussion 269-71. PubMed ID: 14960966
[TBL] [Abstract][Full Text] [Related]
16. Results of a pilot multicenter genotype-based randomized placebo-controlled trial of propranolol to reduce pain after major thermal burn injury.
Orrey DC; Halawa OI; Bortsov AV; Shupp JW; Jones SW; Haith LR; Hoskins JM; Jordan MH; Bangdiwala SI; Roane BR; Platts-Mills TF; Holmes JH; Hwang J; Cairns BA; McLean SA
Clin J Pain; 2015 Jan; 31(1):21-9. PubMed ID: 25084070
[TBL] [Abstract][Full Text] [Related]
17. [Effects of unified surgical scheme for wounds on the treatment outcome of patients with extensive deep burn].
Tang W; Li X; Deng Z; Zhang Z; Zhang X; Zhang T; Zhong X; Chen B; Liu C
Zhonghua Shao Shang Za Zhi; 2015 Aug; 31(4):254-8. PubMed ID: 26715635
[TBL] [Abstract][Full Text] [Related]
18. Comparing oil based ointment versus standard practice for the treatment of moderate burns in Greece: a trial based cost effectiveness evaluation.
Carayanni VJ; Tsati EG; Spyropoulou GC; Antonopoulou FN; Ioannovich JD
BMC Complement Altern Med; 2011 Dec; 11():122. PubMed ID: 22132709
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human growth hormone for treating burns and donor sites.
Breederveld RS; Tuinebreijer WE
Cochrane Database Syst Rev; 2012 Dec; 12():CD008990. PubMed ID: 23235668
[TBL] [Abstract][Full Text] [Related]
20. [The effect of growth hormone on wound healing rate in adult burns].
Sun Y; Zhou Y; Jiang Z
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1998 Jul; 14(4):277-80. PubMed ID: 10680493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
